Medication Fact Sheets
|
January 14, 2025

Cyclobenzaprine 101: A Patient-Friendly Overview

Written By
Medically Reviewed by
Dr. Ayesha Bryant MSPH, MD
Updated On
January 23, 2025

Muscle pain and spasms are common, affecting nearly 40-60% of adults at some point. These issues can interfere with daily activities, making even simple tasks difficult. For those experiencing persistent muscle discomfort, medications like cyclobenzaprine can provide valuable relief.

Cyclobenzaprine is a widely prescribed muscle relaxant that helps ease pain and stiffness caused by muscle spasms. It is an option for short-term recovery, often used alongside rest and physical therapy. In this guide, we’ll explore the key details of cyclobenzaprine, including its uses, safety considerations, and tips for informed decision-making.

[signup]

Understanding Cyclobenzaprine

Cyclobenzaprine is a prescription muscle relaxant to relieve pain and stiffness caused by acute muscle spasms. It is distinct from pain relievers in that it acts on the central nervous system to address muscle hyperactivity. Unlike pain relievers, cyclobenzaprine focuses on calming the muscles to provide relief.

How Cyclobenzaprine Works

Cyclobenzaprine’s exact mechanism of action is not fully understood, but it is believed to act on the central nervous system (CNS), specifically the brainstem, to reduce muscle hyperactivity. It blocks certain chemicals in the brain, called serotonin and norepinephrine, which make muscles overactive. 

It also connects with special parts of the brain called serotonin receptors to help reduce muscle spasms. This allows it to ease tight, painful muscles without affecting how your muscles normally work. In simpler terms, cyclobenzaprine tells your brain to relax muscles, helping you feel less stiff or sore.

Who Should Consider Cyclobenzaprine?

Cyclobenzaprine is FDA-approved for the short-term treatment of acute muscle spasms associated with musculoskeletal conditions. It is not intended for chronic muscle conditions or long-term treatment. 

Proper Use of Cyclobenzaprine

Cyclobenzaprine is available in two forms: immediate-release tablets and extended-release capsules.

  • Immediate-Release Tablets: Commonly prescribed at 5-10 mg, taken 2-3 times daily, based on the patient’s needs and tolerance.
  • Extended-Release Capsules: Typically prescribed at 15-30 mg, taken once daily for up to 3 weeks,

The specific dosage depends on the patient’s age, overall health, and the severity of the muscle spasms. A healthcare provider should determine dosage instructions and must align with FDA-approved recommendations provided in the prescribing information.

Duration of Use and Expected Results

Cyclobenzaprine is meant for short-term use, generally no longer than 2-3 weeks per FDA labeling. Muscle spasms caused by acute conditions often improve within this period, especially when the medication is combined with rest, physical therapy, and other supportive measures. 

It is not intended for long-term management of chronic muscle conditions. Patients may notice symptom relief within a few hours after the first dose, but consistent improvement is typically seen over several days.

Safe Storage and Handling

To preserve the efficacy of cyclobenzaprine:

  • Store it at room temperature (68-77°F) in a dry location away from moisture and heat.
  • Keep the medication in its original container, tightly closed, and out of reach of children or pets.
  • Dispose of unused or expired medication safely, following local pharmacy or community disposal guidelines.

Proper storage and handling help ensure the medication’s effectiveness and reduce the risk of accidental misuse.

Safety and Side Effects

Cyclobenzaprine is generally well-tolerated, but like all medications, it can cause side effects. The most common side effects include:

  • Drowsiness: Feeling unusually sleepy or fatigued.
  • Dry Mouth: A decrease in saliva production, leading to a dry or sticky sensation.
  • Dizziness: A sense of lightheadedness or unsteadiness.

These side effects ary mild and may improve as the body adjusts to the medication. For a full list of potential side effects, consult your healthcare provider or refer to the FDA-approved prescribing information. 

Patients are encouraged to discuss any persistent or bothersome symptoms with their healthcare provider.

Rare But Serious Reactions

While uncommon, some patients may experience more serious reactions, such as:

  • Allergic Reactions: Symptoms include swelling of the face, lips, or tongue, difficulty breathing, and hives. Seek immediate medical attention if these occur.
  • Serotonin Syndrome: This rare but potentially life-threatening condition can occur if cyclobenzaprine is taken with other medications that affect serotonin levels, such as certain antidepressants. Symptoms include confusion, rapid heart rate, high blood pressure, and severe agitation.

Contraindications and Warnings

Certain groups of people are at higher risk of complications when using cyclobenzaprine, including:

  • Elderly Adults: Increased sensitivity to side effects in the elderly compared to younger adults, such as sedation and dizziness.
  • Individuals with Liver Conditions: Reduced ability to metabolize the medication may increase the risk of side effects.
  • People with Heart Conditions: Those with arrhythmias or recent heart attacks may be advised to avoid cyclobenzaprine.

Interaction Warnings

Avoid consuming alcohol or using other central nervous system (CNS) depressants while taking cyclobenzaprine, as these can amplify side effects like drowsiness and impaired coordination.

Inform your healthcare provider about your medications and supplements to avoid potential interactions.

Interactions with Other Drugs and Substances

Cyclobenzaprine can interact with certain medications, potentially increasing the risk of side effects or diminishing its effectiveness. Some drug interactions include:

  • MAO Inhibitors (e.g., phenelzine, tranylcypromine): Combining cyclobenzaprine with MAO inhibitors can cause dangerous reactions, such as high blood pressure, seizures, or serotonin syndrome. Avoid using cyclobenzaprine within 14 days of stopping an MAO inhibitor.
  • Antidepressants (e.g., SSRIs, SNRIs, tricyclic antidepressants): These drugs can increase serotonin levels and elevate the risk of serotonin syndrome when taken with cyclobenzaprine.
  • CNS Depressants (e.g., benzodiazepines, opioids): Using cyclobenzaprine alongside these medications may amplify sedative effects, leading to extreme drowsiness, slowed breathing, or impaired coordination.

Alcohol and Cyclobenzaprine

Combining cyclobenzaprine with alcohol is strongly discouraged because it can significantly increase the risk of side effects. Alcohol enhances the sedative effects of cyclobenzaprine, which can lead to severe drowsiness, fatigue, and impaired coordination. 

This combination also affects judgment and reaction times, raising the likelihood of accidents, including falls or issues while driving. To ensure safety, avoid drinking alcohol while taking this medication.

Over-the-Counter Medications to Avoid

Certain over-the-counter (OTC) medications can interact negatively with cyclobenzaprine and should be used with caution. Cold and allergy medications like diphenhydramine or pseudoephedrine may worsen side effects like drowsiness, dry mouth, and dizziness. 

While pain relievers like ibuprofen or acetaminophen are not strictly prohibited, it is important to consult a healthcare provider before using them alongside cyclobenzaprine. Sleep aids, including melatonin or doxylamine, can increase sedation when combined with cyclobenzaprine, potentially leading to oversedation or respiratory issues. 

When to Seek Medical Attention

Immediate medical attention is necessary if you experience symptoms of an overdose, such as extreme drowsiness, confusion, or an irregular heartbeat. Signs of an allergic reaction, like swelling of the face or difficulty breathing, also require urgent care. 

Additionally, seek help if you notice severe dizziness, sudden confusion, or symptoms of serotonin syndrome, such as agitation or fever. If any symptoms feel unusual or severe, consult your healthcare provider promptly.

Patient Tips and FAQs

Before starting cyclobenzaprine, it’s important to discuss your medical history and current medications with your doctor to ensure safety. Ask about the proper dosage for your condition, potential interactions with other medications or supplements, and how long you should take the medication. 

Understanding the common side effects, like drowsiness or dizziness, can also help you prepare for safe use. Plan to take cyclobenzaprine when you don’t need to drive or operate machinery, especially during the initial days of treatment.

Frequently Asked Questions

Can I drive after taking cyclobenzaprine?

Driving or operating machinery is not recommended after taking cyclobenzaprine due to its sedative effects, which may impair reaction time and coordination.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember unless it’s near the time for your next scheduled dose. In that case, skip the missed dose and continue your regular schedule. Avoid taking two doses at once.

[signup]

Key Takeaways

  • Cyclobenzaprine is a prescription muscle relaxant primarily used for short-term relief of muscle pain and spasms caused by acute injur. It is often combined with rest and physical therapy for optimal results.
  • The medication works by calming overactive muscles through its effects on the central nervous syst. Still, it can cause side effects like drowsiness, dry mouth, and dizziness, making activities like driving unsafe during use.
  • Cyclobenzaprine is not recommended for long-term use or chronic muscle conditions, and it must be avoided in combination with alcohol, certain antidepressants, or MAO inhibitors due to serious interaction risks like serotonin syndrome.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Amy. (2024, October 9). Why Is Cyclobenzaprine Contraindicated in Heart Failure? Cardiovascular Disease Hub; Cardiovasculardiseasehub.com. https://www.cardiovasculardiseasehub.com/archives/9632

Bertagna, B. (2024, January 8). Melatonin for sleep: Unlocking the power of this hormone for restful nights. Rupa Health. https://www.rupahealth.com/post/melatonin-for-sleep-unlocking-the-power-of-this-hormone-for-restful-nights

Brott, N. R., & Reddivari, A. K. R. (2021). Doxylamine. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551646/

Bryant, A. (2024a, August 2). Understanding Arrhythmias: Types, Symptoms, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/arrhythmias-basics-types-symptoms-diagnosis-treatment

Bryant, A. (2024b, September 6). Physical Therapy and Exercise for Rheumatoid Arthritis: Benefits and Tips. Rupa Health. https://www.rupahealth.com/post/physical-therapy-and-exercise-for-rheumatoid-arthritis-benefits-and-tips

Bryant, A. (2024c, October 25). Lab Tests for Patients with Dry Mouth and Eyes. Rupa Health. https://www.rupahealth.com/post/lab-tests-for-patients-with-dry-mouth-and-eyes

Chen, C., Hennessy, S., Brensinger, C. M., Dawwas, G. K., Acton, E. K., Bilker, W. B., Chung, S. P., Dublin, S., Horn, J. R., Miano, T. A., Phuong, T., Soprano, S. E., & Leonard, C. E. (2022). Skeletal muscle relaxant drug–drug–drug interactions and unintentional traumatic injury: Screening to detect three‐way drug interaction signals. British Journal of Clinical Pharmacology, 88(11), 4773–4783. https://doi.org/10.1111/bcp.15395

Cleveland Clinic. (2023, February 7). Muscle relaxers. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/24686-muscle-relaxers

Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cloyd, J. (2023b, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia

Cyclobenzaprine HCL 10mg tablets. (2017). Nih.gov. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=afcad582-ab59-4f70-e053-2a95a90a04e4

Cyclobenzaprine (Oral Route) Description and Brand Names - Mayo Clinic. (n.d.). Www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/cyclobenzaprine-oral-route/description/drg-20063236

Cyclobenzaprine SDS, Safety Data Sheets - ECHEMI. (2019). Echemi.com. https://www.echemi.com/sds/cyclobenzaprinehcl-pid_Seven23441.html?utm_source=chatgpt.com

Cyclobenzaprine: What Is It? Side Effects & Interactions. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19212-cyclobenzaprine-tablets

FLEXERIL ® (CYCLOBENZAPRINE HCL) TABLETS. (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf

Gerriets, V., Anderson, J., & Nappe, T. M. (2020). Acetaminophen. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29493991/

Keegan, M. T., Brown, D. R., & Rabinstein, A. A. (2006). Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs. Anesthesia and Analgesia, 103(6), 1466–1468. https://doi.org/10.1213/01.ane.0000247699.81580.eb

Khan, I., & Kahwaji, C. I. (2022). Cyclobenzaprine. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/30020734/

Kobayashi, H., Hasegawa, Y., & Ono, H. (1996). Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. European Journal of Pharmacology, 311(1), 29–35. https://doi.org/10.1016/0014-2999(96)00402-5

Mayo Clinic. (n.d.). Cyclobenzaprine (Oral Route) Description and Brand Names - Mayo Clinic. Www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/cyclobenzaprine-oral-route/description/drg-20063236

National Institute of Neurological Disorders and Stroke. (2023). Pain. Www.ninds.nih.gov. https://www.ninds.nih.gov/health-information/disorders/pain

Ngo, V. T. H., & Bajaj, T. (2021). Ibuprofen. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/31194439/

NHS. (2018, September 21). Diphenhydramine (including Nytol Original & Histergan): drowsy antihistamine. Nhs.uk. https://www.nhs.uk/medicines/diphenhydramine/

Norepinephrine. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/norepinephrine

Robinson, K. (2024, September 11). Cyclobenzaprine 101: A Complete Patient-Friendly Overview. Rupa Health. https://www.rupahealth.com/post/muscle-cramps-in-hands-diagnosis-treatment-and-prevention

Rosenlicht, N. Z., & Riley-Lazo, K. P. (2005). Interactions of cyclobenzaprine and tricyclic antidepressants. The Journal of Clinical Psychiatry, 66(1), 134–135. https://doi.org/10.4088/jcp.v66n0118b

Serotonin. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/serotonin

Singh, K., Senatorov, I. S., Cheshmehkani, A., Karmokar, P. F., & Moniri, N. H. (2022). The Skeletal Muscle Relaxer Cyclobenzaprine Is a Potent Non-Competitive Antagonist of Histamine H1 Receptors. Journal of Pharmacology and Experimental Therapeutics, 380(3), 202–209. https://doi.org/10.1124/jpet.121.000998

Stauffer, K. (2024, December 10). Cyclobenzaprine: Benefits, Dosage Options, and Warnings. Rupa Health. https://www.rupahealth.com/post/cyclobenzaprine-benefits-dosage-options-and-warnings?utm_source=chatgpt.com

T, P. (2015). Long-term Use of Cyclobenzaprine for Pain: A Review of the Clinical Effectiveness. In PubMed. Canadian Agency for Drugs and Technologies in Health. https://pubmed.ncbi.nlm.nih.gov/25763449/

Tahrier Sub Laban, & Abdolreza Saadabadi. (2023, July 17). Monoamine oxidase inhibitors (MAOI). Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539848/

Weinberg, J. L. (2024, February 13). Allergic Skin Reactions: A Functional Medicine Approach to Identifying and Treating Root Causes. Rupa Health. https://www.rupahealth.com/post/allergic-skin-reactions-a-functional-medicine-approach-to-identifying-and-treating-root-causes

Welsh, T. P., Yang, A. E., & Makris, U. E. (2020). Musculoskeletal Pain in Older Adults. The Medical Clinics of North America, 104(5), 855–872. https://doi.org/10.1016/j.mcna.2020.05.002

Winchell, G. A., King, J. D., Chavez-Eng, C. M., Constanzer, M. L., & Korn, S. H. (2002). Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic Insufficiency. The Journal of Clinical Pharmacology, 42(1), 61–69. https://doi.org/10.1177/0091270002042001007

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.